Open access

1095 CD51 as a newly identified immunomodulatory protein: investigating expression and function on CD8 T cells
Solhwi Lee, Se Jin Im

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1204; DOI: 10.1136/jitc-2023-SITC2023.1095
1097 New immunomodulatory roles of NONO pathway during glioma virotherapy
Andrew G Gillard, Dong Ho Shin, Hong Jiang, Xuejun Fan, Virginia Laspidea, Jiasen He, Andres Lopez-Rivas, Akhila Parthasarathy, Marta Alonso, Frederick Lang, Juan Fueyo, Candelaria Gomez Manzano

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1206-A1208; DOI: 10.1136/jitc-2023-SITC2023.1097
1098 Oncolytic HSV blocking tumor-intrinsic PKR sensitizes glioblastoma to immunotherapy
Bangxing Hong, Upasana Sahu, Balveen Kaur

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1209; DOI: 10.1136/jitc-2023-SITC2023.1098
1099 Activating neutrophils by combining immunogenic recombinant modified vaccinia virus Ankara and granulocyte colony stimulating factor for the treatment of malignant peripheral nerve sheath tumor
Yueqi Wang, Juan Yan, Shuaitong Liu, Shanza Baseer-Tariq, Bharath Salla, Liangliang Ji, Ming Li, Ping Chi, Liang Deng

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1210; DOI: 10.1136/jitc-2023-SITC2023.1099
1100 Immunovirotherapy with the codon-modified influenza virus CodaLytic™ modulates the quality of the tumor immune infiltrate in support of anti-tumor immunity
Yiwen Zhao, Nusrat Jahan, Katarina Blagovic, Steffen Mueller, J Robert Coleman, Johanna K Kaufmann

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1211; DOI: 10.1136/jitc-2023-SITC2023.1100
1101 Activation of myeloid cells suppresses metastatic ovarian cancer via tumoricidal neutrophils and IL-27-secreting macrophages
Taito Miyamoto, Brennah Murphy, Bryan Manning, Toshitha Kannan, Daniel Claiborne, Rugang Zhang, Andrew Kossenkov, Nan Zhang

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1212; DOI: 10.1136/jitc-2023-SITC2023.1101
1102 The HLA-E/NKG2A axis is a dominant immunomodulatory pathway associated with distinct tumor microenvironment features in a subset of NSCLC
Kerryan Ashley, Krishna Iyer, Rakesh Kumar, Zachary A Cooper, Roy S Herbst, Sarah Goldberg, Kurt Schalper

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1213; DOI: 10.1136/jitc-2023-SITC2023.1102
1103 Spatial mapping and clinical significance of the CD39/CD73 adenosinergic pathway as a candidate immunotherapy target in non-small cell lung cancer
Kerryan Ashley, Krishna Iyer, Rakesh Kumar, Zachary A Cooper, Roy S Herbst, Sarah Goldberg, Kurt Schalper

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1214; DOI: 10.1136/jitc-2023-SITC2023.1103
1104 Identification of effective treatment regimens for ovarian cancer using tumor histoculture platform
Biswajit Das, Kowshik Jaganathan, Rohit Ranade, C Jaya Prakash, Ravi Krishnappa, V Syamkumar, Chandan Bhowal, M Mouniss, M Dharanidharan, M Rajashekar, M Oliyarasi, Ritu Malhotra, K Govindraj, Mohit Malhotra, Nandini P Basak, Satish Sankaran

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1215; DOI: 10.1136/jitc-2023-SITC2023.1104
1105 Tumor cell autonomous innate immune signaling drives therapeutic resistance in head and neck tumors
Alexander Frey, Curtis Perry, Kathyrn Clulo, Lotus Lum, Mackenzie Bender, Barbara Burtness, Kelly Olino, Jeffrey Ishizuka

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1216-A1217; DOI: 10.1136/jitc-2023-SITC2023.1105

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages